...
首页> 外文期刊>Trends in Endocrinology and Metabolism: TEM >Estrogens and cell-cycle regulation in breast cancer.
【24h】

Estrogens and cell-cycle regulation in breast cancer.

机译:乳腺癌中的雌激素和细胞周期调控。

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical and experimental data have established that the leading cause of sporadic female breast cancer is exposure to estrogens, predominantly 17beta-estradiol. Recent advances in the understanding of cell-cycle control mechanisms have been applied to outline the molecular mechanisms through which estrogens regulate the cell cycle in cultured breast cancer cells, in particular, in MCF-7 cells. Here, we discuss how estrogens exert control over several key G1 phase cell-cycle regulators, namely cyclin D1, Myc, Cdk2, Cdk4, Cdk inhibitors and Cdc25A. Although the molecular mechanisms underlying estrogenic regulation of G1 phase regulators are far from clear, current evidence indicates that estrogens might regulate several key molecules required for S phase entry, this regulation being independent of cell-cycle transit per se.
机译:临床和实验数据已经确定,散发性女性乳腺癌的主要原因是接触雌激素,主要是17β-雌二醇。在细胞周期控制机制的理解上的最新进展已被应用于概述分子机制,通过该分子机制雌激素调节培养的乳腺癌细胞,特别是MCF-7细胞中的细胞周期。在这里,我们讨论了雌激素如何控制几个关键的G1期细胞周期调节剂,即细胞周期蛋白D1,Myc,Cdk2,Cdk4,Cdk抑制剂和Cdc25A。尽管目前尚不清楚G1期调节因子的雌激素调节作用的分子机制,但目前的证据表明,雌激素可能调节进入S期所需的几个关键分子,这种调节作用本身与细胞周期的传递无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号